[1]
2025. A new RP- HPLC Method Development and Validation for the Concurrent Identification of Nivolumab and Hyaluronidase in Bulk and Pharmaceutical Dosage Form. Asian Journal of Chemical and Pharmaceutical Research. 13, 1 (Jun. 2025), 47–52. DOI:https://doi.org/10.30904/j.ajcpr.2025.4812.